written by reader Matthew McLal $8 stock

by goblue16 | February 12, 2020 4:22 pm

What is the stock Matthew McCall is pumping now?

InvestorPlace

Dear Reader,

My newest buy recommendation went live today.

It’s an $8 stock inside an industry that’s growing over 50% year after year.

This microcap company has FDA[1]-approval for a breakthrough technology that medical doctors are already praising.

The bad new is, you are NOT currently subscribed to receive this investment research.

This could be the biggest missed opportunity of 2020.

The microcap I’ve pinpointed as our newest “buy” has a tiny $164 million market cap.

But it could soar tenfold or more as this market continues to grow each year.

Don’t miss out on this incredible opportunity to position yourself for a profitable 2020.

My full analysis on this microcap — including how much you can expect to make — just went live on my website.

But as I said, you are not currently enrolled to receive it. There is still time to rectify this situation, though.

Click here to learn how to add your name to my list.

Sincerely,

Matt McCall[2]
Senior Investment Strategist, InvestorPlace

You are receiving this message because you opted in to receive information about our upcoming campaigns from InvestorPlace. If you don’t want to receive messages about this campaign in the future you can unsubscribe here but you will no longer receive reminders and supporting content for this campaign

MANAGE YOUR INVESTORPLACE ACCOUNT:

We hope this timely investing advice is valuable to you. As you know the markets move fast and conditions change frequently. So please check the current issue for the most recent advice.

To make sure you received the most recent updates, please tell us if your email has changed by emailing us at feedback@investorplace.com[3].

Go here to unsubscribe.

Go here for Billing FAQs.

InvestorPlace Media, LLC.
9201 Corporate Blvd, Suite 200
Rockville, MD 20850

If you have any questions call 1-800-219-8592.

Copyright © 2020 InvestorPlace Media, LLC.

All rights reserved.

Please note that we cannot be liable for any missed bulletins caused by overzealous filters. To ensure that you continue to receive this valuable part of your service please take a moment to add (MattMcCall@exct.Investorplace[4].com) to your address book. Go here for instructions:
http://www.investorplace.com/whitelist.html?eml=MattMcCall@exct.Investorplace.com[5]

Endnotes:
  1. FDA: https://www.stockgumshoe.com/tag/fda/
  2. Matt McCall: https://www.stockgumshoe.com/tag/matt-mccall/
  3. feedback@investorplace.com: mailto:feedback@investorplace.com
  4. Investorplace: https://www.stockgumshoe.com/tag/investorplace/
  5. http://www.investorplace.com/whitelist.html?eml=MattMcCall@exct.Investorplace.com: http://www.investorplace.com/whitelist.html?eml=MattMcCall@exct.Investorplace.com

Source URL: https://www.stockgumshoe.com/2020/02/microblog-matthew-mclal-8-stock/


One response to “written by reader Matthew McLal $8 stock”

  1. audi4cc says:

    Looks like a job for the Thinkolator” to decipher.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.